Literature DB >> 30589950

Treatment of diffuse large B-cell lymphoma in elderly patients: Replacing doxorubicin with either epirubicin or etoposide (VP-16).

Roosa Enni Inkeri Prusila1,2, Pekka Peroja1,2, Esa Jantunen3,4,5, Taina Turpeenniemi-Hujanen1,2, Outi Kuittinen2,6,7.   

Abstract

Entities:  

Keywords:  DLBCL; elderly; treatment

Mesh：

Substances：

Year:  2019        PMID： 30589950     DOI： 10.1002/hon.2572

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN： 0278-0232            Impact factor:   5.271


× No keyword cloud information.
  4 in total

1.  Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas.

Authors:  Xuan Zhou; Sanfang Tu; Chunsheng Wang; Rui Huang; Lan Deng; Chaoyang Song; Chunyan Yue; Yanjie He; Jilong Yang; Zhao Liang; Anqin Wu; Meifang Li; Weijun Zhou; Jingwen Du; Zhenling Guo; Yongqian Li; Cheng Jiao; Yuchen Liu; Lung-Ji Chang; Yuhua Li
Journal:  Front Immunol       Date:  2020-11-27       Impact factor: 7.561

2.  Treatment of Primary Mediastinal B-Cell Lymphoma With R-CEOP (Rituximab, Cyclophosphamide, Etoposide, Vincristine, and Prednisone).

Authors:  Sundar V Cherukuri; Amit Sureen; Taylor Infante; Nevetha Rajendran; Osvaldo Padilla; Sumit Gaur
Journal:  Cureus       Date:  2021-07-02

3.  Systems Drug Discovery for Diffuse Large B Cell Lymphoma Based on Pathogenic Molecular Mechanism via Big Data Mining and Deep Learning Method.

Authors:  Shan-Ju Yeh; Tsun-Yung Yeh; Bor-Sen Chen
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

4.  Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity.

Authors:  Luigi Rigacci; Ombretta Annibali; Sofya Kovalchuk; Elisabetta Bonifacio; Francesca Pregnolato; Francesco Angrilli; Umberto Vitolo; Samantha Pozzi; Serena Broggi; Stefano Luminari; Francesco Merli; Michele Spina; Silvia Bolis; Gloria Margiotta-Casaluci; Rosario Scalzulli; Christina Cox; Angela Maria Mamusa; Armando Santoro; Pier Luigi Zinzani; Samantha Ferrari; Guido Gini; Maria Luigia Vigliotti; Antonino Mulè; Leonardo Flenghi
Journal:  Hematol Oncol       Date:  2020-07-09       Impact factor: 5.271
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.